Atlas Trials

Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin

Clinical trial NCT04502888 · TERMINATED

Trial details

NCT number
NCT04502888
Sponsor
Shattuck Labs, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Cutaneous Squamous Cell CarcinomaSquamous Cell Carcinoma of Head and Neck
Start date
2020-09-17
Primary completion
2022-04-08
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.